| Primary |
| Hypertension |
66.2% |
| Pregnancy Induced Hypertension |
6.0% |
| Drug Exposure During Pregnancy |
4.3% |
| Diabetes Mellitus |
3.4% |
| Depression |
3.0% |
| Anaemia |
2.6% |
| Essential Hypertension |
1.7% |
| Insomnia |
1.7% |
| Acid Base Balance Abnormal |
1.3% |
| Zinc Deficiency |
1.3% |
| Arthritis |
0.9% |
| Blood Phosphorus Increased |
0.9% |
| Blood Pressure Increased |
0.9% |
| Diabetes Mellitus Insulin-dependent |
0.9% |
| Diarrhoea |
0.9% |
| Dyspepsia |
0.9% |
| Gastritis |
0.9% |
| Hepatitis C |
0.9% |
| Hypercalcaemia |
0.9% |
| Hypokalaemia |
0.9% |
|
| Liver Disorder |
11.8% |
| Drug Exposure During Pregnancy |
10.6% |
| Pyrexia |
10.6% |
| Protein Urine Present |
7.1% |
| Renal Failure |
5.9% |
| Hepatic Function Abnormal |
4.7% |
| Hypospadias |
4.7% |
| Premature Baby |
4.7% |
| Respiratory Disorder |
4.7% |
| Gamma-glutamyltransferase Increased |
3.5% |
| Haemolytic Anaemia |
3.5% |
| Overdose |
3.5% |
| Pre-eclampsia |
3.5% |
| Proteinuria |
3.5% |
| Renal Failure Acute |
3.5% |
| Small For Dates Baby |
3.5% |
| Unresponsive To Stimuli |
3.5% |
| Congenital Central Nervous System Anomaly |
2.4% |
| Dyspnoea |
2.4% |
| Hepatitis Acute |
2.4% |
|
| Secondary |
| Hypertension |
41.1% |
| Drug Use For Unknown Indication |
13.1% |
| Product Used For Unknown Indication |
9.4% |
| Drug Exposure During Pregnancy |
5.1% |
| Maternal Exposure Timing Unspecified |
4.0% |
| Diabetes Mellitus |
3.5% |
| Bipolar Disorder |
3.3% |
| Migraine |
2.5% |
| Hiv Infection |
2.2% |
| Convulsion |
2.0% |
| Gestational Hypertension |
2.0% |
| Acute Myocardial Infarction |
1.7% |
| Type 2 Diabetes Mellitus |
1.5% |
| Antiemetic Supportive Care |
1.3% |
| Anxiety |
1.3% |
| General Anaesthesia |
1.3% |
| Infection |
1.3% |
| Insomnia |
1.3% |
| Anaesthesia |
1.2% |
| Acid Base Balance Abnormal |
1.0% |
|
| Premature Baby |
13.2% |
| Maternal Exposure During Pregnancy |
6.6% |
| Pulmonary Oedema |
6.6% |
| Renal Failure |
6.6% |
| Threatened Labour |
6.6% |
| Drug Exposure During Pregnancy |
5.7% |
| Interstitial Lung Disease |
5.7% |
| Renal Aplasia |
5.7% |
| Headache |
4.7% |
| Umbilical Cord Abnormality |
4.7% |
| Ventricular Septal Defect |
4.7% |
| Abortion Spontaneous |
3.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.8% |
| Protein Urine Present |
3.8% |
| Solitary Kidney |
3.8% |
| Hypospadias |
2.8% |
| Hypotension |
2.8% |
| Pulmonary Arterial Hypertension |
2.8% |
| Renal Failure Acute |
2.8% |
| Tricuspid Valve Disease |
2.8% |
|
| Concomitant |
| Hypertension |
40.8% |
| Product Used For Unknown Indication |
22.3% |
| Rheumatoid Arthritis |
4.8% |
| Drug Use For Unknown Indication |
4.6% |
| Depression |
2.7% |
| Asthma |
2.5% |
| Diabetes Mellitus |
2.3% |
| Anxiety |
2.2% |
| Prophylaxis |
2.2% |
| Disseminated Tuberculosis |
2.0% |
| Renal Transplant |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Foetal Exposure During Pregnancy |
1.6% |
| Blood Pressure |
1.4% |
| Insomnia |
1.4% |
| Bipolar Disorder |
1.3% |
| Bronchitis |
1.2% |
| Contraception |
1.2% |
| Hyperlipidaemia |
1.2% |
| Blood Cholesterol Increased |
1.1% |
|
| Premature Baby |
11.8% |
| Ventricular Septal Defect |
8.3% |
| Drug Exposure During Pregnancy |
7.7% |
| Hypertension |
7.7% |
| Maternal Exposure During Pregnancy |
7.7% |
| Vomiting |
5.9% |
| Renal Impairment |
5.3% |
| Weight Increased |
5.3% |
| Premature Labour |
4.1% |
| Sudden Death |
4.1% |
| Death |
3.6% |
| Sepsis |
3.6% |
| Tenderness |
3.6% |
| Weight Decreased |
3.6% |
| Diarrhoea |
3.0% |
| Polyhydramnios |
3.0% |
| Pre-eclampsia |
3.0% |
| Pyrexia |
3.0% |
| Renal Failure |
3.0% |
| Renal Failure Acute |
3.0% |
|
| Interacting |
| Hypertension |
66.7% |
| Back Pain |
33.3% |
|
|
